Vaccine Specialist and Advisor @ (March 2022 - Present)
President @ Avanda Biolabs Limited (February 2019 - Present)
Strategic Advisor @ Infectious disease and cancer vaccines, Immunotherapy, Adjuvants and combination (April 2016 - Present)
Cancer Vaccine Advisor @ (March 2022 - March 2024)
Strategic Business Development Advisor @ AELIX Therapeutics (July 2019 - December 2023)
Chief Science and Business Officer @ (June 2016 - February 2022)
Chief Executive Officer @ (June 2014 - March 2016)
Chief Science Officer and Chief Operating Officer @ (January 2011 - June 2014)
VP Research and Development @ (January 2006 - January 2010)
Head Research Scientist @ (January 2001 - January 2006)
Marc Mansour Education
Master's
MBA (Business Administration)
2008-2013
Doctorate
PhD (Biology)
1994-2002
Marc Mansour Skills
Immunology
Vaccines
Executive Management
Product Development
Clinical Development
Immunotherapy
Business Strategy
Oncology
Infectious Diseases
Pre-clinical R&D
Patents
Intellectual Property
R
Biotechnology
R&D
Research and Development (R&D)
Management
Pre Clinical R&d
Sales
Molecular Biology
Marketing
Research and Development R&d
Research and Development
Marc Mansour Summary
Marc Mansour, based in Canada, is currently a Chief Technology Officer at Virometix AG. Marc Mansour brings experience from previous roles at NEC Bio Therapeutics GmbH, Avanda Biolabs Limited, Infectious disease and cancer vaccines, Immunotherapy, Adjuvants and combination and NEC OncoImmunity AS. Marc Mansour holds a 2008 - 2013 MBA in Business Administration @ Master's. With a robust skill set that includes Immunology, Vaccines, Executive Management, Product Development, Clinical Development and more. Marc Mansour has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Marc Mansour?
Find contact details for 700 million professionals.